Symbols

RCUS

Arcus Biosciences·NYSE

--(--)

5.28 / 10

Netural

Analyst sentiment is bullish with 66.7% Strong Buy and 33.3% Buy, though track records are mixed. Fund‑flow rating is good (7.48), showing inflows for small, medium and large investors but outflows for block and extra‑large, indicating uneven buying pressure.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

67%

Buy

33%

Hold

Sell

Strong Sell

Date2026-03-02

InstitutionHC Wainwright & Co.

Times predicted3

Historical Win Rate33.3%

What is the market sentiment for RCUS?

RCUS holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.28/10 (Netural).